Bisphosphonate safety and efficacy in chronic kidney disease.
Level V
Where this comes from
- Record sourced from PubMed, PMID 23018824.
- Also identified by DOI 10.1038/ki.2012.253.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new population-based study of elderly patients hospitalized for a fracture and treated with an oral bisphosphonate finds no increased risk of acute kidney injury. The safety and efficacy of bisphosphonates may be different in patients with chronic kidney disease (CKD). The effects on vascular calcifications need further study, because low bone turnover might exacerbate vascular calcifications in patients with CKD. Even if bisphosphonates prove safe, their efficacy in this population is uncertain.
Medical subject headings
- Acute Kidney Injury
- Bone Density Conservation Agents
- Diphosphonates